Form 4: Director Acquires Saul Centers Stock via Deferred Plan
Insider Transaction Report
Saul Centers Director George Patrick Clancy Jr. acquired 3,690 shares of common stock through the conversion of phantom shares under a deferred compensation plan.
Summary
- George Patrick Clancy Jr., a Director at Saul Centers, Inc. (BFS), acquired 3,690 shares of common stock.
- The acquisition occurred on January 5, 2026, at a price of $31.5 per share.
- This transaction was a conversion (Code 'M') of 3,690 phantom shares into common stock.
- The phantom shares were issued under the Issuer's Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024, under its 2024 Stock Incentive Plan.
- Following this transaction, Mr. Clancy directly beneficially owns 20,605 shares of common stock and 3,689.856 phantom shares.
- He also holds various Director Stock Options, each for 2,500 shares, with exercise prices ranging from $33.79 to $59.41 and expiration dates between May 6, 2026, and May 12, 2033.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. The transaction is a routine conversion under a compensation plan, indicating a director's continued equity accumulation, which is generally seen as a positive sign of alignment with shareholder interests. No new strategic information or significant market-moving events are disclosed.
Positives
- A director is increasing their direct ownership in the company, which can signal confidence in the company's future performance.
- The transaction is part of a pre-existing deferred compensation plan, indicating a structured approach to executive compensation and alignment of interests.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing.
Industry Context
This filing is a routine insider transaction report and does not provide broader industry context. It reflects an individual director's equity compensation and ownership within Saul Centers, Inc.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Plan Amendment | The Issuer's Deferred Compensation Plan for Directors was amended and restated, effective May 17, 2024, under its 2024 Stock Incentive Plan. | 05/17/2024 | This amendment updates the terms governing phantom shares for directors, potentially affecting future equity compensation and alignment of interests. |
Related Party Transactions
- The acquisition of common stock by a director through a deferred compensation plan is a related party transaction, as it involves an equity transaction between the company and one of its fiduciaries.
Stakeholder Impact
- Shareholders: Increased director ownership may signal confidence, potentially aligning director interests with long-term shareholder value.
- Employees: The existence of a structured deferred compensation plan for directors indicates a framework for executive incentives, which can indirectly influence overall compensation philosophy.
Next Steps
- The remaining Director Stock Options will expire between May 6, 2026, and May 12, 2033, and may be exercised prior to their expiration dates.
- Future phantom shares issued on or after May 17, 2024, will be governed by the amended and restated Deferred Compensation Plan under the 2024 Stock Incentive Plan.
Key Dates
| Date | Description |
|---|---|
| 05/06/2016 | Date exercisable for Director Stock Option with exercise price $57.74, expiring 05/06/2026. |
| 05/05/2017 | Date exercisable for Director Stock Option with exercise price $59.41, expiring 05/05/2027. |
| 05/11/2018 | Date exercisable for Director Stock Option with exercise price $49.46, expiring 05/11/2028. |
| 05/03/2019 | Date exercisable for Director Stock Option with exercise price $55.71, expiring 05/03/2029. |
| 04/24/2020 | Date exercisable for Director Stock Option with exercise price $50, expiring 04/24/2030. |
| 05/07/2021 | Date exercisable for Director Stock Option with exercise price $43.89, expiring 05/07/2031. |
| 05/13/2022 | Date exercisable for Director Stock Option with exercise price $47.9, expiring 05/13/2032. |
| 05/09/2023 | Date exercisable for Director Stock Option with exercise price $33.79, expiring 05/12/2033. |
| 05/17/2024 | Effective date of the amended and restated Deferred Compensation Plan for Directors under the 2024 Stock Incentive Plan. |
| 01/05/2026 | Date of acquisition of 3,690 common shares and conversion of 3,690 phantom shares. |
| 01/06/2026 | Signature date of the reporting person's power of attorney. |
| 05/06/2026 | Expiration date for Director Stock Option with exercise price $57.74, exercisable from 05/06/2016. |
| 05/05/2027 | Expiration date for Director Stock Option with exercise price $59.41, exercisable from 05/05/2017. |
| 05/11/2028 | Expiration date for Director Stock Option with exercise price $49.46, exercisable from 05/11/2018. |
| 05/03/2029 | Expiration date for Director Stock Option with exercise price $55.71, exercisable from 05/03/2019. |
| 04/24/2030 | Expiration date for Director Stock Option with exercise price $50, exercisable from 04/24/2020. |
| 05/07/2031 | Expiration date for Director Stock Option with exercise price $43.89, exercisable from 05/07/2021. |
| 05/13/2032 | Expiration date for Director Stock Option with exercise price $47.9, exercisable from 05/13/2022. |
| 05/12/2033 | Expiration date for Director Stock Option with exercise price $33.79, exercisable from 05/09/2023. |
Recommendation
holdThis Form 4 filing reports a routine insider transaction where a director acquired shares through a pre-existing deferred compensation plan. While an increase in director ownership is generally positive, this specific transaction is not indicative of new market-moving information or a discretionary open-market purchase that would warrant a change in investment recommendation. It primarily reflects the execution of a compensation agreement. Investors should continue to hold based on broader company fundamentals and market conditions, as this filing does not present new information to alter a fundamental view.
Keywords
Saul Centers, BFS, Insider Trading, Form 4, Director Stock Acquisition, Phantom Stock, Deferred Compensation, Equity Compensation, Real Estate Investment Trust, REIT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.